Akshay Vaishnaw, President, R&D at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 14,387 shares at $137.60 ($2.0M) on 2021-04-21, disclosed to the SEC on 2021-04-21.
Open-market sale of $2.0M ALNY by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $136.76 | 1,678 | $229K | 11.7% |
| 2 | $136.76 | 1,678 | $229K | 11.7% |
| 3 | $137.60 | 989 | $136K | 6.9% |
| 4 | $137.60 | 989 | $136K | 6.9% |
| 5 | $138.64 | 622 | $86K | 4.4% |
| 6 | $138.64 | 622 |
| $86K |
| 4.4% |
| 7 | $140.02 | 417 | $58K | 3.0% |
| 8 | $140.02 | 417 | $58K | 3.0% |
| 9 | $131.75 | 2,266 | $299K | 15.2% |
| 10 | $134.56 | 85 | $11K | 0.6% |
| 11 | $135.41 | 203 | $27K | 1.4% |
| 12 | $136.84 | 1,892 | $259K | 13.2% |
| 13 | $136.84 | 1,892 | $259K | 13.2% |
| 14 | $137.60 | 530 | $73K | 3.7% |
| 15 | $138.48 | 107 | $15K | 0.8% |
| Total | $136.47 avg | 14,387 | $2.0M | 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-08-07 | $1.4M | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |